Study provides molecular rationale for combining targeted agents to treat breast cancer
COLUMBUS, Ohio — A new study by Ohio State University cancer researchers provides a rational for treating breast cancer by combining two kinds of targeted agents, one that inhibits an overactive, cancer-causing pathway in cancer cells and one that…